| Wapsi Valley Family Counseling, Llc | |
|
805 Charles St Masonville IA 50654-8516 | |
| (319) 361-4867 | |
| (563) 927-3939 |
| Full Name | Wapsi Valley Family Counseling, Llc |
|---|---|
| Speciality | Social Worker - Clinical |
| Location | 805 Charles St, Masonville, Iowa |
| Authorized Official Name and Position | Jacquelyn Kay Schultz (OWNER) |
| Authorized Official Contact | 3193614867 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Wapsi Valley Family Counseling, Llc 805 Charles St Masonville IA 50654-8516 Ph: (319) 361-4867 | Wapsi Valley Family Counseling, Llc 805 Charles St Masonville IA 50654-8516 Ph: (319) 361-4867 |
| NPI Number | 1639466709 |
|---|---|
| Provider Enumeration Date | 07/08/2011 |
| Last Update Date | 05/06/2022 |
| Certification Date | 05/06/2022 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639466709 | NPI | - | NPPES |
| 600931888 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 04543 (Iowa) | Primary |
| 251S00000X | Community/behavioral Health | 04543 (Iowa) | Secondary |
News Archive
A new study out of Western University (London, Canada) has found a significant decline in speeding-related fatalities and injuries among young men in Ontario since the province's tough extreme speeding and aggressive driving laws were introduced in 2007.
Failing to disclose the results of clinical trials kills patients and wastes money, and government regulation is needed to put a stop to it, argues Sir Iain Chalmers in a letter to this week's BMJ.
Ingen Technologies, Inc., is an ISO Certified and FDA Registered medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company sells their patented and proprietary Oxyview and SMART Nasal Cannula along with their most recent released INGEN Pulse Oximeter. Today the company announced Proxy results and growth plans.
An international study looking at DNA from over 26,000 people has identified several genetic variants that substantially increase susceptibility to asthma in the population. The findings, published in the New England Journal of Medicine, will help scientists to focus their efforts to develop better therapies for the illness.
› Verified 6 days ago